Buscar
Congreso SOLACI

Búsqueda de: DES

Si no está conforme con los resultados, inténtelo de nuevamente.
Chronic Coronary Syndromes

ESC 2024 | REC-CAGEREE I Trial: Drug Coated Balloon with Bailout Stenting vs. Intended DES for de Novo Lesion Treatment

DES stenting is currently the standard treatment. The development of balloon technology and the coating drugs have...
Dr. Omar Tupayachi -
Ir
Coronary disease

Recurrent Revascularization at 10 Years after Percutaneous Treatment of DES In-Stent Restenosis

In stent restenosis (ISR) continues to be the main limitation to the percutaneous treatment of coronary artery...
solaci -
Ir
Institutional News

Left Main PCI with Dedicated DES Guided by HD Imaging | SOLACI-SBHCI 2023, International Live Case

✔️ SOLACI-SBHCI 2023 - Internationl Live Case | Left Main PCI with Dedicated DES Guided by HD...
solaci -
Ir
Chronic Ischemic cardiopathy

TCT 2023 | ISAR-DESIRE 3: 10-Year Results

In-stent restenosis (ISR) remains the primary limitation of percutaneous treatment for coronary artery disease. The strategy to...
solaci -
Ir
Institutional News

The former presidents of SOLACI and SBHCI received their well-deserved tribute during the SOLACI-SBHCI 2023 Congress

During the SOLACI-SBHCI 2023 Congress, a special session was held to honor the great figures of interventional...
solaci -
Ir
Coronary disease

ISAR Score: Can We Predict the Need for Repeat PCI in DES Restenosis?

Score to predict the risk of repeat PCI in DES restenosis. With the use of drug eluting stents...
solaci -
Ir
Coronary disease

BIODEGRADE: Does Stent Design Affect Long-Term Clinical Results?

Recent studies have shown that drug-eluting stents with biodegradable polymer and ultrathin struts are safe and effective,...
solaci -
Ir
SOLACI-SBHCI 2016 Presentations

Mitos e verdades sobre o uso de antiplaquetários na intervenção percutânea

By Dr. Roberto Esporcatte.
solaci -
Ir

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad